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Abstract: Plant extracts of Eugenia punicifolia (Kunth) DC., Myrtaceae, are 
used in Amazon region of Brazil to treat diarrhea and stomach disturbances, 
and as hypoglycemic medicine. We have recently shown that an aqueous extract 
of E. punicifolia augmented cholinergic neurotransmission in a rat phrenic 
nerve-diaphragm preparation. In this study, we investigated the effects of an E. 
punicifolia dichloromethane extract (EPEX) in a neuronal model of cholinergic 
neurotransmission, the bovine adrenal chromaffin cell. EPEX augmented the release 
of catecholamine triggered by acetylcholine (ACh) pulses but did not enhance ACh-
evoked inward currents, which were inhibited by 30%. Since EPEX did not cause 
a blockade of acetylcholinesterase or butyrylcholinesterase, it seems that EPEX is 
not directly activating the cholinergic system. EPEX also augmented K+-elicited 
secretion without enhancing the whole-cell inward calcium current. This novel and 
potent effect of EPEX in enhancing exocytosis might help to identify the active 
component responsible for augmenting exocytosis. When elucidated, the molecular 
structure of this active principle could serve as a template to synthesise novel 
compounds to regulate the exocytotic release of neurotransmitters.
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Introduction
 Historically, there is a long tradition investigating 
the pharmacological profi le of plant extracts and looking 
for new active compounds with potential therapeutic 
interest. This strategy has given rise to many new 
compounds that lead to the synthesis of new chemical 
entities to treat several diseases (Marcaurelle & Johannes, 
2008). Our interest is in determining natural product 
extracts with pharmacological activity, and we recently 
became interested in studying the cholinergic effects of 
Eugenia punicifolia (Kunt) DC., Myrtaceae, a plant that 
grows in the Amazonia forests of Brazil. We studied the 
effects of a 5% (w/v) aqueous extract of E. punicifolia on 
cholinergic neurotransmission at the muscle endplate (rat 
phrenic nerve-diaphragm preparation), and we found that 
this extract augmented neurotransmission mediated by 
nicotinic receptors for acetylcholine (nAChR) (Grangeiro 
et al., 2006).
 Our laboratory has a long-standing interest in 
the search for compounds with potential capabilities for 
cholinergic neurotransmission enhancement. With this 
enhancement, we expect these compounds to improve 
cognition in Alzheimer’s disease (AD) patients, as is 
the case for galantamine, rivastigmine or donepezil, 
three inhibitors of acetylcholinesterase (AChE) and 
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butyrylcholinesterase (BuChE) (Marco-Contelles et 
al., 2006; Marco & do Carmo Carreiras, 2006). For the 
last decade, we have been designing and synthesising 
novel hybrid compounds with multi-target profiles, 
such as inhibiting AChE and/or BuChE, the modulation 
of nAChR and neuronal calcium (Ca2+) signalling, or 
neuroprotection against different neurotoxic stimuli 
(de los Rios et al., 2002; Leon et al., 2005; Orozco et 
al., 2006; de los Rios et al., 2010). In this context, 
we hypothesised that the E. punicifolia extract that 
enhances cholinergic neurotransmission in the rat 
diaphragm (Grangeiro et al., 2006) could also augment 
nAChR-mediated catecholamine release responses in 
adrenal medullary chromaffin cells. This could further 
stimulate investigations identifying the possible active 
component(s) in the extract and eventually serve as a 
starting point for a program synthesising new compounds 
aimed at optimising the natural active compound.
 In this study, we have chosen the chromaffin cell 
because it is considered an excellent model for studies 
on basic mechanisms of neuronal communication, Ca2+ 
signalling, and exocytosis linked to nAChR (Garcia et 
al., 2006; Livett et al., 2006). We report here that an E. 
punicifolia extract (EPEX) augmented the release of 
catecholamines from bovine chromaffin cells stimulated 
with either acetylcholine (ACh) or with high K+ 
concentrations. In elucidating the mechanisms involved 
in such augmentation, we also investigated the effects 
of EPEX on ACh-elicited inward currents (IACh), Na
+ 
channel currents (INa), Ca
2+ channel currents (ICa) and 
cytosolic Ca2+ concentrations ([Ca2+]c). Furthermore, we 
also investigated EPEX effects on the activity of both 
purified AChE and BuChE enzymes.
Material and Methods 
Plant material and preparation of crude extracts
 Eugenia punicifolia (Kunth) DC., Myrtaceae, 
was kindly supplied by Centro de Instrução de Guerra na 
Selva (Manaus-AM, Brazil) and was identified at Museu 
Nacional, UFRJ (Brazil), where voucher specimens were 
kept for future reference. The official authorisation to 
investigate this plant was given by Instituto Brasileiro 
de Meio Ambiente e Recursos Renováveis, Brazil, and 
it was registered under the number 16602-1. The plant 
was successively extracted at room temperature with 
solvents of increasing polarity beginning with n-hexane, 
then dichloromethane and finally methanol. The extracts 
were concentrated under reduced pressure to yield oily 
(hexane extract) or solid (dichloromethane and methanol 
extracts) residues, and they were stored at 4 °C. Stock 
solutions were prepared at 1 mg/mL in 10-2 M DMSO. 
Appropriate dilutions of the solutions were made for 
each experiment. All experiments in this study used the 
dichloromethane extract (EPEX). Appropriate controls 
with this solvent were made and no significant effects 
were observed in the presence of DMSO in any of the 
experimental protocols (see below) used in this study.
Measurement of AChE activity
 The effect of EPEX on acetylcholinesterase 
(AChE) activity was determined following the method 
of Ellman et al. (Ellman et al., 1961) using AChE from 
Electrophorus electricus (Electric eel; eeAChE) and 
acetylthiocholine iodide (0.35 mM) as substrate. The 
reaction took place in a final volume of 3 mL and consisted 
of a phosphate buffer solution at pH 8.0 containing 
0.035 U of eeAChE and 0.35 mM of 5,5’-dithiobis-2-
nitrobenzoic acid (DTNB), at 25 °C. The yellow anion 
5-thio-2-nitrobenzoic acid is produced as the enzymatic 
reaction proceeds. After a 10-min preincubation of the 
enzyme with different EPEX concentrations, the substrate 
was added and the enzymatic reaction was allowed to 
proceed for 15 additional min. A sample without EPEX 
was always present as a negative control to determine 
100% of enzymatic activity, along with a sample 
containing 100 nM tacrine as a reference compound 
(Guillou et al., 2000). After the 15-min incubation period, 
the production of colour as an indication of enzymatic 
activity was evaluated by measuring absorbance at 410 
nm in a spectrophotometer plate reader (iEMS Reader 
MF, Labsystems).
Measurement of BuChE activity
 The effect of EPEX on butyrylcholinesterase 
(BuChE) was also determined following the method of 
Ellman et al. (Ellman et al., 1961) using BuChE from 
horse serum (eqBuChE) and butyrylthiocholine iodide 
(0.5 mM) as the substrate. The reaction took place at a 
final volume of 3 mL and consisted of a phosphate buffer 
solution at pH 8.0 containing 0.05 U of eqBuChE and 
0.35 mM DTNB. The yellow anion 5-thio-2-nitrobenzoic 
acid is produced as the enzymatic reaction proceeds. 
The enzyme was pre-incubated for 10 min with different 
concentrations of EPEX. After this time, the substrate was 
added and the enzymatic reaction was allowed to proceed 
for an additional 15 min, at 25 °C. A sample without EPEX 
was always present, as a negative control, to determine 
the 100% of enzymatic activity, along with a sample 
containing 100 nM tacrine as a reference compound 
(Guillou et al., 2000). After the 15-min incubation period, 
the production of colour as an indication of enzymatic 
activity was evaluated by measuring absorbance at 410 
nm in a spectrophotometer plate reader (iEMS Reader 
MF, Labsystems).
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Isolation and culture of adrenal medulla chromaffin 
cells
 Bovine adrenal glands were obtained from 
a local slaughterhouse. Adrenal medulla chromaffin 
cells were isolated following standard methods (Livett, 
1984) with some modifications (Moro et al., 1990). 
Cells were suspended in DMEM supplemented with 5% 
foetal calf serum, 10 µM cytosine arabinoside, 10 µM 
fluorodeoxyuridine, 50 IU/mL penicillin, and 50 µg/mL 
streptomycin. For the patch-clamp studies, cells were 
plated on 1-cm diameter glass coverslips at a low density 
(5x104 cells per coverslip). For the catecholamine release 
measurements, cells were plated on 5-cm diameter 
Petri dishes at 5x106 cells per dish. To study changes 
in cytosolic Ca2+ levels ([Ca2+]c), cells were plated at a 
density of 2x105 cells/well in 96-well black dishes.
On-line measurements of catecholamine release
 Bovine chromaffin cells were scrapped off 
carefully from the bottom of the Petri dishes with a rubber 
policeman and centrifuged at 800 rpm for 10 min. The 
cell pellet was resuspended in a 200 µL Krebs-HEPES 
solution at pH 7.4 (in mM: 144 NaCl, 5.9 KCl, 1.2 MgCl2, 
11 glucose, 10 N-(2-hydroxyethyl) piperazine-N´-(2-
ethanesulfonic acid) (HEPES)). Cells were placed in a 
microchamber for their superfusion at the rate of 2 mL/
min at 37 °C in the Krebs-HEPES solution. Under these 
conditions, the cell superfusion fluid emanating from the 
microchamber was measured with a thermistor probe 
and showed a temperature of 35 °C. For the detection 
of released catecholamines, the liquid flowing from the 
superfusion chamber reached an electrochemical detector 
(model CH-9100; Metrohm AG, Herisau, Switzerland) 
equipped with a glassy carbon working electrode, an Ag/
AgCl reference electrode and a gold auxiliary electrode. 
Catecholamines are oxidised at +0.65 V and the oxidation 
current was recorded on a PC computer (Borges et al., 
1986). 
 Cells were stimulated to secrete with short pulses 
(5 s) of a Krebs-HEPES solution containing either 35 or 
70 mM K+ or 100 μM acetylcholine, in the absence or 
presence of different extract concentrations (See Results). 
Solutions were rapidly exchanged through electrovalves 
operated by a computer.
Patch-clamp current measurements and analysis
 Inward currents through voltage-gated Ca2+ 
channels (IBa), voltage-gated Na
+ (INa), and nAChR 
(IACh) were recorded using the whole-cell configuration 
of the patch-clamp technique (Hamill et al., 1981). 
Whole-cell recordings were made with fire-polished 
electrodes (resistance 2-5 MΩ when filled with the 
standard intracellular solutions) that were mounted on 
the headstage of an EPC-9 patch-clamp amplifier (Heka 
Electronic, Lambrecht, Germany), allowing cancellation 
of capacitative transients and compensation of series 
resistance. Data were acquired with a sample frequency of 
20 kHz by using PULSE 8.74 software (Heka Elektronik, 
Lambrecht, Germany). Linear leak and capacitative 
components were substracted by using a P/4 protocol 
and series resistance was compensated by 80%. The data 
analysis was performed with Igor Pro (Wavemetrics, Lake 
Oswego, OR) and PULSE programs (Heka Elektronik). 
 Coverslips containing the cells were placed on an 
experimental chamber mounted on the stage of a Nikon 
Diaphot inverted microscope. Cells were continuously 
superfused with a control Tyrode solution at pH 7.4 
containing (in mM): 137 NaCl, 1 MgCl2, 2 CaCl2, 10 
HEPES/NaOH. Once the patch membrane was ruptured 
and the whole-cell configuration of the patch-clamp 
technique had been established, the cell was locally, 
rapidly and constantly superfused with an extracellular 
solution of similar composition to the chamber solution, 
but containing nominally 0 mM Ca2+ to measure INa, 2 
mM Ca2+ to measure IACh, or 10 mM Ba
2+ (instead of Ca2+) 
to measure IBa (see Results for specific experimental 
protocols). Cells were internally dialysed with an 
intracellular solution containing (in mM): 100 CsCl, 14 
EGTA, 20 TEA.Cl, 10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 
20 HEPES⁄CsOH (pH 7.3). The external solutions were 
rapidly exchanged using electronically driven miniature 
solenoid valves coupled to a multi-barrel concentration-
clamp device, the common outlet of which was placed 
within 100 μm of the cell to be patched. The flow rate 
was 1 mL/min and regulated by gravity. 
 Cells were held at -80 mV; Na+ currents were 
generated by 15 ms depolarizing pulses to -10 mV, Ba2+ 
currents were generated by 50 ms depolarizing pulses 
at 0 or +10 mV; nAChR currents were generated by 
the application of 250 ms ACh pulses (100 μM). All 
experiments were performed at room temperature (24±2 
°C) on cells from 2 to 4 days after culture.
Measurement of [Ca2+]c 
 Cells were plated at a density of 2x105 cells 
per well into 96-well plates, and the experiments were 
performed 48 h later. Cells were loaded with a Krebs-
HEPES solution at pH 7.4 (in mM: 144 NaCl, 5.9 KCl, 
1.2 MgCl2, 2 CaCl2, 11 D-glucose, and 10 HEPES) 
containing 10 µM fluo-4-AM and 0.2% pluronic acid. 
The cells were incubated in this solution for 45 min at 
37 °C in the dark. After this incubation period, cells 
were washed twice with the Krebs-HEPES solution at 
room temperature in the dark. Changes in fluorescence 
(excitation 485 nm, emission 520 nm) were measured 
using a fluorescent plate reader (Fluostar, BMG Labtech, 
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Offenburg, Germany). Basal levels of fluorescence 
were monitored before adding the stimulation solution 
(containing 100 μM acetylcholine) with an automatic 
dispenser. After stimulation of the cells, changes in 
fluorescence were measured for 40 s. To normalise fluo-4 
signals, responses from each well were calibrated by 
measuring maximum and minimum fluorescence values. 
At the end of each experiment, 3% Triton X-100 (Fmax) 
was added followed by 0.2 M MnCl2 (Fmin). Data were 
calculated as a percentage of Fmax-Fmin.
Reagents
 Collagenase type A from Clostridium 
histolyticum was purchased from Boehringer-Mannheim 
(Madrid, Spain). Dulbecco’s modified Eagle’s medium 
(DMEM), bovine serum albumin fraction V, foetal 
calf serum and antibiotics were purchased from Gibco 
(Madrid, Spain). Collagenase type I from Clostridium 
histolyticum, 3-aminobenzoic acid ethyl ester, and 
acetylcholine chloride came from Sigma Chemical Co. 
(St Louis, MO). The agonist (ACh) was freshly prepared 
in cold water and diluted to the desired concentration in 
the extracellular solution.
Data analysis
 The results are presented as mean±SE. The 
measurements of peak current and charge that flow 
through the channel after its activations were calculated 
with the program Clampfit 5.03. IC50 values were 
estimated through non-linear regression analysis using 
Origin software (OriginLab Corporation, Northampton, 
USA). Comparisons between means of group data were 
performed by one-way analysis of variance (ANOVA) 
followed by the Duncan post-hoc test when appropriate. 
p≤0.05 was taken as the limit of significance.
Results
Effects of EPEX on catecholamine release elicited by 
repeated ACh pulsing in chromaffin cells
 Because EPEX was previously shown to enhance 
neurotransmission at the muscle endplate (rat phrenic 
nerve-diaphragm preparation) (Grangeiro et al., 2006), 
we first explored whether the extract had the capability 
of augmenting the exocytotic release of catecholamines. 
Thus, an electrochemical detector working under the 
amperometric mode was used to measure the real-time 
rate of catecholamine release from bovine chromaffin 
cell populations (around 5 million cells per experiment). 
These cells were trapped in a microchamber and fast-
perfused with a Krebs-HEPES solution containing 2 mM 
Ca2+. In each experiment, cells were initially perfused for 
a 5 to 10-min period to allow the stabilisation of basal 
secretion (around 10 nA). Accumulated experience in our 
laboratory shows that these cells give highly reproducible 
amperometric secretory responses upon repeated pulses 
applied at regular intervals, using solutions containing 
supramaximal concentrations of ACh (Santos et al., 
2001; Cuchillo-Ibáñez et al., 2002; Tapia et al., 2009). 
We used 3-s pulses of solutions containing 100 μM ACh 
(100 ACh), which in a previous study were found to fully 
deplete the ready-releasable vesicle pools under these 
experimental conditions and produce a maximal peak 
secretory response (Cuchillo-Ibáñez et al., 2002). 
 Figure 1A shows a prototypical experiment 
using repeated 3-s 100 ACh pulses given at 5-min 
intervals. Note that the peak of the initial secretory spike 
of 200 nA was maintained fairly constant throughout 
the experiment. Using this protocol, we surprisingly 
found that at the low concentration of 0.1 ng/mL, EPEX 
gradually augmented the ACh-evoked, catecholamine 
release response, reaching an amplitude 2.5 fold higher 
than the initial response (Figure 1B). As shown in 
Figure 1B, basal catecholamine release was not affected 
by EPEX perfusion; however, upon EPEX washout, 
the response quickly returned to initial levels and was 
enhanced once more upon reperfusion of the extract. 
Pooled data plotted in Figure 1C shows EPEX causing a 
gradual increase in catecholamine secretion, which was 
maintained for 15 min and reversed upon EPEX washout. 
However, we did not find an obvious concentration-
dependence for the secretion-enhancing effects of EPEX 
that seemed to augment this response even more at 0.1 
ng/mL than at 1 and 5 ng/mL, although there were no 
statistical differences between the three concentrations 
(Figure 1D).
Effects of EPEX on ACh-elicited inward currents
 In trying to elucidate the mechanism involved in 
the enhancement of ACh-evoked catecholamine release 
elicited by EPEX, we explored the possibility that the 
extract was modifying the ACh-elicited inward currents 
(IACh). Thus, we performed experiments in voltage-
clamped cells using the whole-cell configuration of the 
patch-clamp technique.
 Figure 2A shows an example of the original 
IACh obtained upon repeated application of 100 μM ACh 
pulses to the same cell. In this cell, the initial IACh peak 
amplitude was 968 pA. In subsequent ACh pulses, IACh 
was maintained fairly well. Figure 2B shows a protype 
experiment in which the initial IACh was reduced by 37% in 
the presence of 1 ng/mL EPEX, and this current reduction 
was readily reversible upon the extract washout. Figure 
2C shows the pooled averaged results of experiments 
performed in 34 cells. At EPEX concentrations within the 
range of 0.01-1 ng/mL, IACh progressively decreased to 
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2001). We performed experiments on the basis of the 
following previous findings: i) augmentation of synaptic 
transmission at the muscle endplate elicited by EPEX 
could be due to inhibition of AChE and BuChE (Grangeiro 
et al., 2006); ii) drugs inhibiting AChE and BuChE have 
proven to have beneficial effects in Alzheimer’s disease 
patients (Schmidt et al., 2008; van Marum, 2008) and iii) 
inhibition of AChE and BuChE could explain the EPEX-
elicited augmentation of ACh-evoked catecholamine 
release responses.
 Figure 3 shows the concentration response 
curves for enzyme inhibition by tacrine, a well-known 
inhibitor of both AChE and BuChE (Summers et al., 
1986). As expected, tacrine inhibited both enzymes in 
a concentration-dependent manner, with an IC50 for 
BuChE at 2.0 nM, and 25 nM for AChE. In contrast, the 
concentrations of EPEX that augmented ACh-evoked 
63% of the initial current, and higher concentrations (10-
100 ng/mL) did not produce additional blockade. EPEX 
washout produced a partial current recovery.
 We also tested whether EPEX could affect other 
ionic channels by measuring the TTX-sensitive sodium 
current (INa) in voltage-clamped (-80 mV) cells. We 
found no effect of EPEX on such current at 0.1 and 1 ng/
mL (data not shown).
Effects of EPEX on the activities of AChE and BuChE
 Since the effects of EPEX in enhancing ACh-
stimulated catecholamine release did not seem to be 
associated with a direct action on nAChR, we wanted 
to know whether EPEX affected the activities of two 
enzymes involved in the rapid degradation of ACh at 
synaptic sites, AChE and BuChE (Kutty, 1980; Buchwald, 
Figure 1. EPEX augments the release of catecholamines triggered by acetylcholine (ACh) pulses. Chromaffin cells (5x106) were 
trapped in a microchamber and perfused with Krebs-HEPES solution. Once stabilised, the basal catecholamine release was between 
10 and 20 nA. (A) Representative experiment in which cells were stimulated with a solution containing 100 μM ACh for 5 s at 3-min 
intervals (dots at the bottom). (B) Cells received three ACh pulses at the beginning of the experiment and then they were perfused 
with EPEX at 0.1 ng/mL for the time periods indicated by the two horizontal bars at the bottom. (C) Pooled results of experiments 
performed with the protocols shown in panel A (control cells) and B (EPEX-treated cells). (D) Effects of increasing concentrations 
of EPEX given for 30 min on ACh-evoked catecholamine release responses. Data in panels C and D were normalised as the percent 
of the initial secretion in each individual experiment and are given as mean±SE. of the number of experiments shown in parentheses. 
**p<0.005 and ***p<0.001, with respect to the corresponding control point (panel C) or the initial secretion (panel D).
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secretion (0.1-1 ng/mL, Figure 1 B and D) or even 1000-
fold higher concentrations of EPEX, did not affect the 
activities of AChE or BuChE.
Figure 2. EPEX causes a concentration-dependent mild 
inhibition of the inward whole-cell current generated by ACh 
pulses. Cells were voltage-clamped at -80 mV. Upon breaking 
into the cell, ACh pulses (100 μM, 250 ms) were sequentially 
applied to each individual cell at 60 s intervals. (A) An example 
cell stimulated with ACh pulses that produced inward IACh. 
(B) An example cell showing the IACh traces obtained before 
(initial), 3 min after perfusion with EPEX, and 3 min after 
extract washout. (C) Pooled results obtained in cells that were 
sequentially stimulated with ACh pulses before (initial IACh)
 
and 3 min after perfusion with increasing concentrations of 
EPEX (bottom horizontal bar). Each concentration was tested 
in a different cell. Data were normalised as the percent of IACh 
amplitude obtained initially and are represented as mean±SE 
of 34 cells from five different cultures. *p<0.05, **p<0.01, and 
***p<0.001, with respect to initial IACh amplitude. 
Effects of EPEX on catecholamine release responses 
triggered by repeated application of high-K+ pulses
 The sequence of events leading to the coupling 
between ACh stimulation and the secretory response 
(Douglas, 1968) include cell depolarization, opening of 
voltage-activated Ca2+ channels (VACC) and exocytosis 
(Garcia et al., 2006). Because EPEX did not seem to 
augment secretion through a cholinergic-mediated 
pathway, we explored the possibility that the extract 
could act on VACC to enhance secretion. We therefore 
triggered secretion with direct depolarization of the 
cell membrane with a solution containing 70 mM K+ 
(70K+). At this concentration, the bovine chromaffin cell 
membrane potential depolarizes to near 0 mV (Orozco et 
al., 2006) and opens all VACC (Garcia et al., 2006).
Figure 3. EPEX did not affect the activities of 
acetylcholinesterase (AChE) and butyrylcholinesterase 
(BuChE). Purified AChE from Electrophorus electricus or 
BuChE from horse serum were incubated with EPEX at the 
concentrations indicated on the abscissa. Tacrine was used 
as a positive control. In each individual experiment, the 
maximal enzyme activities (100%) were determined in the 
presence of vehicle, and enzyme activities were determined 
in the presence of EPEX or tacrine, expressed as the percent 
of maximal activity. Data are represented as mean±SE from 
eight wells from at least two different experiments.
 Figure 4A shows the secretory spikes obtained 
in a representative experiment with cells challenged 
with repeated 5-s, 70 mM K+ pulses given at 3 min 
intervals. The initial secretory responses of 200 nA 
showed an amplitude similar to spikes elicited by ACh 
pulses (Figure 1A). These responses gradually declined 
with time to amplitudes of around 70% of the initial 
responses. Similar to ACh, EPEX also augmented the 
K+-evoked responses, and this increase developed more 
rapidly than with ACh, reaching about 2.5 times the 
initial spike amplitude (Figures 1B and 4B). The reason 
for such a difference may be explained because we used 5 
ng/mL EPEX in the K+ experiments, a concentration 50-
fold higher than that used in the ACh experiments. Figure 
4C shows the pooled results of the effects of EPEX on 
K+-induced catecholamine secretion. The augmentation 
of the secretion elicited by EPEX seems to be gradual, 
similar to that of ACh (Figures 1C and 4C). Figure 4D 
shows pooled results of experiments performed with 
increasing concentrations of EPEX, and the 0.1 and 1 ng/
mL concentrations that enhanced ACh responses had no 
effect on the K+ responses. In contrast, 5 ng/mL of EPEX 
almost doubled the initial K+ secretory response.
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Effects of EPEX on inward currents through Na+ and 
Ca2+ channels
 High K+ concentrations will induce a cell 
membrane depolarization allowing the opening of 
voltage-gated Na+ channels and VACC to enhance Ca2+ 
entry, [Ca2+]c and catecholamine secretion. Thus, EPEX-
elicited enhanced secretion could be due to augmentation 
of Ca2+ entry through VACC. The most direct way of 
testing this possibility was measuring the whole-cell 
inward currents through VACC. Thus, we performed 
experiments aimed to test the possible effects of EPEX 
on voltage-gated Na+ and Ca2+ channels by recording 
whole-cell inward currents through these channels.
 Figure 5A shows original recordings of INa 
(left panel) and IBa (right panel) elicited by 15 or 50 ms 
depolarizing pulses (see protocol on top or the original 
recordings), in the absence and/or the presence of EPEX 
(0.1 and 1 ng/mL). The peak Na+ current density in cells 
from different batches was 42.15±6.65 pA/pF (n=8) 
and the peak Ba2+ current density in cells from different 
batches was 45.63±4,13 pA/pF (n=15). Averaged results 
obtained with these experimental protocols showed that 
INa was not significantly modified in the presence of EPEX 
(left panel in Figure 5B), and only a mild (around 10%), 
not significant, decrease of IBa at 0.1-1 ng/mL EPEX 
was observed. Figure 5C shows current-voltage curves 
generated by increasing voltage-step depolarizations. 
Peak current was reached at 0-+10 mV and was reduced 
by 5-10% in the presence of 1 ng/mL EPEX; however, no 
shift of the current-voltage (I-V) curve was found during 
cell treatment with the extract.
Figure 4. EPEX augmented the release of catecholamines from cells repeatedly stimulated with K+-enriched solutions. Cells 
were initially perfused with Krebs-Hepes solution and, once baseline secretion was stable, cells were challenged for 5 s 
every 3 min with a solution containing 70 mM K+ (with low Na+) (dots at the bottom). (A) An example cell showing initial 
secretion spikes of 200 nA. This spike amplitude was maintained during the first five initial pulses and declined by 20% at 
the end of the experiment. (B) An example cell perfused with EPEX during the period indicated by the bottom horizontal bar. 
(C) Pooled data obtained in different experiments made with the protocols shown in panels A (control) and B (EPEX-treated 
cells). (D) The effects of increasing concentrations of EPEX on K+-evoked secretion. Data in panels C and D are normalised 
as a percent of the initial response in each individual experiment and are represented as mean±SE. ***p<0.001, with respect 
to the corresponding time in control cells (panel C) and ***p<0.001, with respect to the initial secretion (panel D).
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Figure 5. EPEX did not significantly modify the whole-cell inward currents through voltage-gated sodium (INa) and calcium 
(IBa) channels. Cells were voltage-clamped at -80 mV and step-depolarising pulses (15 ms to -10 mV for INa, and 50 ms to 
+10 mV for IBa; see protocol on top of figure) were sequentially applied at 10-s intervals. Panel (A) shows original recordings 
of INa (left panel) and IBa (right panel) recorded in the absence and/or the presence of EPEX (0.1 and 1 ng/mL). In panel (B) 
averaged results obtained with these experimental protocols show that INa was not significantly modified in the presence of 
EPEX (left panel; n=8), and only a mild (around 10%; right panel; n=15), not significant, decrease of IBa at 0.1-1 ng/mL EPEX 
was observed. Panel (C) shows current-voltage curves generated by increasing voltage-step depolarizations. Peak current was 
reached at 0-+10 mV and was reduced by 5-10% in the presence of 1 ng/mL EPEX (n=11);. No shift of the current-voltage 
(I-V) curve was found during cell treatment with the extract. Data are mean±SE.
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Effects of EPEX on the elevations of cytosolic calcium 
concentrations ([Ca2+]c ) elicited by ACh
 In bovine chromaffin cells, ACh pulses cause 
depolarisation and action potentials that give rise to 
transient [Ca2+]c elevations (de Diego et al., 2008). Such 
Ca2+ signals are the result of Ca2+ entry through nAChR 
via VACC, or from Ca2+ release from the endoplasmic 
reticulum (Garcia et al., 2006). Thus, we tested whether 
EPEX could alter this ACh-elicited Ca2+ signal to explain 
its ability to augment depolarization-evoked secretion.
 Fluo-4-loaded cells were challenged with ACh 
pulses in the absence or the presence of increasing 
concentrations of EPEX. Figure 6A shows two 
fluorescence records indicating [Ca2+]c elevations elicited 
by ACh (bottom black horizontal bar), before (left) and 
during the application of 0.1 ng/mL EPEX, as indicated 
by the bottom horizontal grey bar. EPEX slightly 
augmented the rate and amplitude of the ACh-evoked 
[Ca2+]c elevation. Pooled results are given in Figure 6A, 
showing that at 0.1 and 0.3 ng/mL, EPEX augmented 
the [Ca2+]c elevation by 7 and 12%, respectively (not 
significant). At greater concentrations, the extract did not 
change the ACh-evoked [Ca2+]c elevation.
 Discussion
 In this study, we found that an extract of the 
plant E. punicifolia (EPEX) caused an augmentation of 
catecholamine release from bovine adrenal medullary 
cells challenged with ACh (Figure 1) or high K+ (Figure 
4). Both type of stimuli are widely used to trigger 
secretion (both induce cell membrane depolarization 
and subsequently Ca2+ entry through voltage-gated Ca2+ 
channels, but they differ in the fact that ACh-induced 
catecholamine secretion implies the activation of nAChR 
and indirectly depolarize cell membrane, while high 
K+ serves to directly depolarise cell membrane (Garcia 
et al., 2006). We also used electrophysiological and 
Ca2+ imaging techniques to determine the mechanisms 
underlying this potentiation.
 Augmentation of ACh-evoked secretion could 
be due to a direct action of EPEX on nAChR by behaving 
as an allosteric modulator of α7 nAChR (Faghih et al., 
2007) that have been identified in bovine chromaffin 
cells (Quik et al., 1987; Geertsen et al., 1988; Criado et 
al., 1997; Lopez et al., 1998; Fuentealba et al., 2004). 
However, this does not seem to be the case because i) 
EPEX did not augment IACh, but it mildly inhibited IACh 
at concentrations that augmented exocytosis, suggesting 
that the potentiating effects of EPEX was exerted beyond 
the nAChR (Figure 2) and ii) EPEX also augmented the 
K+-evoked secretion (Figure 4), a stimulus that directly 
depolarises the cells without intervention of nAChR.
 In chromaffin cells, the L-subtype VDCC 
mediates the secretion elicited by K+ depolarization, 
and this response is augmented by the L-type Ca2+ 
channel activator Bayk 8644 (Garcia et al., 1984). 
Thus, we considered the possibility that, similar to 
Bayk 8644, EPEX was acting by enhancing Ca2+ entry 
through L-channels; however, EPEX mildly reduced ICa 
(Figure 5). Although EPEX slightly increased the [Ca2+]
c elevations induced by ACh, this was not significant 
(Figure 6). One possibility is that EPEX could augment 
the quantal content of individual chromaffin vesicles and/
or of the single secretory spike burst, by actin at some 
of the initial steps of exocytosis. This will be tested in 
future experiments on quantal catecholamine release at 
the single cell level, using a carbon fibre microelectrode 
(Miranda-Ferreira et al., 2008; Miranda-Ferreira et al., 
2009)
 Although we have not yet uncovered the 
mechanism of action of EPEX, this study has served 
to unravel an entirely new biological activity for this 
plant extract, augmentation of exocytosis. In Brazil, 
E. punicifolia extracts are employed in Amazon region 
to treat diarrhea and stomach disturbances, and as 
hypoglycemic medicine (Brito et al., 2007; Bopp et 
al., 2009). The mechanism underlying pharmacological 
properties of the genus Eugenia are partially attributed to 
flavonoids (myricitrin, quercetin, and quercetrin), steroids, 
terpenoids, tanines, and anthraquinones (Consolini & 
Sarubbio, 2002). We keep doing experiments on the 
dichloromethane extract used in the presents tudy to gain 
further information on the composition and to identify the 
component/s that could be responsible of the observed 
effects on the cholinergic neurotransmission. 
 Its use for the treatment of diabetes could be 
linked to the augmentation of the exocytotic release of 
insulin in response to hyperglycemia. Also, it is interesting 
that hypoglycaemic drugs block a type of ATP-dependent 
potassium channel, and we cannot rule out that a ligand 
present in the E. punicifolia extract may bind to these 
potassium channels to elicit an effect. Unfortunately, this 
type of channel is not present in bovine chromaffin cells 
and hence we should not explore such possibility. Related 
to the possibility that EPEX could be acting on other K+ 
channel types to regulate the catecholamine secretory 
response, our laboratory found that SK (small conductance 
calcium-activated K+ channels) and BK (big conductance 
calcium-activated K+ channels) were involved in the 
modulation of exocytosis, due to an indirect effect, by Ca2+ 
entering through VDCCs (Uceda et al., 1994; Lara et al., 
1995). However, we did not find any effect of EPEX on 
such currents (not shown). 
 We have discovered a simple and efficient 
biological test for isolating and chemically characterising 
the active compound responsible for the potentiation of 
exocytosis by EPEX. Given the high sensitivity of this 
test to subnanogram concentrations of EPEX and, since 
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submilligram concentrations are sufficient to analyse 
exocytotic release of catecholamines from bovine 
chromaffin cells, testing different fractions of purified 
extracts can be performed. 
 In addition to the identification of the active 
compound in EPEX, our findings have also interested 
us to search for new biological targets and ligands 
with potential therapeutic interest in neurodegenerative 
diseases, particularly in Alzheimer’s disease (Rafii & 
Aisen, 2009). A compound that augments exocytosis 
might also enhance neurotransmission, synaptic plasticity 
and neuronal survival. If the molecular structure of the 
active compound present in EPEX could eventually be 
identified, it could become a prototype for the design 
and synthesis of new compounds capable of improving 
synaptic plasticity and neuronal communication.
 In conclusion, we have discovered that an 
Eugenia punicifolia extract augments the exocytotic 
catecholamine release from bovine adrenal chromaffin 
cells stimulated with ACh or K+. Using catecholamine 
release as a biological probe in subsequent studies, could 
facilitate the isolation of the active compound and the 
elucidation of its molecular structure. This could be used as 
a template to synthesise new derivatives with therapeutic 
potential as cognition enhancers in Alzheimer’s disease 
patients. 
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